Hua Medicine (华领医药) Post-Listing: Thin Volume and Limited Upside
Hua Medicine is the third biotech companies to list in Hong Kong without a profit under the amended listing rules. The stock debuted last Friday...
523 Views
Last Week in GER Research: Meituan, Nio, Haidilao, Shandong Gold, China Renais., X Financial and PDD
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we dig into the economics of Mobike as it relates...
478 Views
ECM Weekly (15 September 2018) - Fast & Furious - NIO, Qutoutiao, Haidilao, Viomi, X Financial
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
723 Views
Last Week in GER Research: Meituan, China Tower, Haidilao, Qutoutiao, Hua Med., Chunlai, and Cootek
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we assess Meituan's latest results ahead of its...
464 Views
ECM Weekly (8 September 2018) - Qutoutiao, Viomi, 111 Inc., Meituan, Haidilao
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
660 Views